Andere Sprachen Hyper Corporation Inc.

Aktien

A065650

KR7065650004

A065650

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 11.06.2024			% 5 Tage	% 1. Jan.
1.409 ^KRW	-0,07 %		-1,19 %	+43,34 %

30.05.	Hyper Corporation Inc. (KOSDAQ:A065650) hat die Übernahme von 31% der Anteile an Fingerlabs Co., Ltd. von FSN Co., Ltd. (KOSDAQ:A214270) und AdQUA Interactive Inc.	CI
30.05.	AdQUA Interactive Inc. hat die Übernahme von 48% der Anteile an Emotion Global, Inc. von Medifron DBT Co., Ltd. (KOSDAQ:A065650).	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hyper Corporation Inc. completed the acquisition of unknown minority stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. and AdQUA Interactive Inc.	30.05.
AdQUA Interactive Inc. completed the acquisition of 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd..	30.05.
Medifron DBT Co., Ltd. completed the acquisition of 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd..	30.05.
Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd.	26.04.
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..	05.04.
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion.	05.04.
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion.	05.04.
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.	28.03.
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion	16.02.
Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding	15.02.
Medifron DBT Co., Ltd. announced that it expects to receive KRW 20.999999826 billion in funding from FSN Co., Ltd.	15.02.
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd	14.12.22
Medifron DBT Co., Ltd.(KOSDAQ:A065650) dropped from S&P Global BMI Index	19.09.22
Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding	24.08.22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 3 billion in funding	22.08.22
Medifron DBT Co., Ltd. announced that it has received KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.	30.06.22
Medifron DBT to Raise $3.9 Million via Stock Offering	22.06.22
Medifron DBT to Raise $10 Million via Stock Offering	22.06.22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.	22.06.22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 12.9999915 billion in funding from Best Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. and other investors	22.06.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hyper Corporation Inc.

Aktien

A065650

KR7065650004

A065650

Andere Sprachen

Filter